Literature DB >> 21532607

The ideal vaccine: until death do us part.

Hildegund C J Ertl1.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21532607      PMCID： PMC3098644          DOI： 10.1038/mt.2011.60

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  13 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

2.  Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine.

Authors:  Chandan Thomas; Amit Rawat; Louisa Hope-Weeks; Fakhrul Ahsan
Journal:  Mol Pharm       Date:  2011-01-11       Impact factor: 4.939

3.  Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.

Authors:  Nia Tatsis; Julie C Fitzgerald; Arturo Reyes-Sandoval; Kimberly C Harris-McCoy; Scott E Hensley; Dongming Zhou; Shih-Wen Lin; Ang Bian; Zhi Quan Xiang; Amaya Iparraguirre; Cesar Lopez-Camacho; E John Wherry; Hildegund C J Ertl
Journal:  Blood       Date:  2007-05-17       Impact factor: 22.113

Review 4.  Perspective: edible vaccines--a concept coming of age.

Authors:  T S Mor; M A Gómez-Lim; K E Palmer
Journal:  Trends Microbiol       Date:  1998-11       Impact factor: 17.079

5.  TLR, NLR Agonists, and Other Immune Modulators as Infectious Disease Vaccine Adjuvants.

Authors:  Sarah C Higgins; Kingston H G Mills
Journal:  Curr Infect Dis Rep       Date:  2010-01       Impact factor: 3.725

Review 6.  Central roles of NLRs and inflammasomes in viral infection.

Authors:  Thirumala-Devi Kanneganti
Journal:  Nat Rev Immunol       Date:  2010-09-17       Impact factor: 53.106

7.  Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge.

Authors:  Scott G Hansen; Cassandra Vieville; Nathan Whizin; Lia Coyne-Johnson; Don C Siess; Derek D Drummond; Alfred W Legasse; Michael K Axthelm; Kelli Oswald; Charles M Trubey; Michael Piatak; Jeffrey D Lifson; Jay A Nelson; Michael A Jarvis; Louis J Picker
Journal:  Nat Med       Date:  2009-02-15       Impact factor: 53.440

8.  Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus.

Authors:  J J Donnelly; A Friedman; D Martinez; D L Montgomery; J W Shiver; S L Motzel; J B Ulmer; M A Liu
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

9.  Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses.

Authors:  James J Moon; Heikyung Suh; Anna Bershteyn; Matthias T Stephan; Haipeng Liu; Bonnie Huang; Mashaal Sohail; Samantha Luo; Soong Ho Um; Htet Khant; Jessica T Goodwin; Jenelyn Ramos; Wah Chiu; Darrell J Irvine
Journal:  Nat Mater       Date:  2011-02-20       Impact factor: 43.841

10.  Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigen.

Authors:  Mauricio A Arias; Andrew Loxley; Christy Eatmon; Griet Van Roey; David Fairhurst; Mark Mitchnick; Philip Dash; Tom Cole; Frank Wegmann; Quentin Sattentau; Robin Shattock
Journal:  Vaccine       Date:  2010-12-09       Impact factor: 3.641
View more
  1 in total

Review 1.  Towards a more effective strategy for COVID-19 prevention (Review).

Authors:  Anna K Szkaradkiewicz-Karpińska; Andrzej Szkaradkiewicz
Journal:  Exp Ther Med       Date:  2020-11-11       Impact factor: 2.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.